Silicone Breast Implant Data Requirements Questioned By Patient Groups
This article was originally published in The Gray Sheet
Executive Summary
FDA's General & Plastic Surgery Devices Panel will likely consider gel migration and "silent rupture" of silicone breast implants when reviewing Inamed's premarket application